{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:31:35Z","timestamp":1781080295295,"version":"3.54.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T00:00:00Z","timestamp":1522713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T00:00:00Z","timestamp":1522713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In many human disorders mitochondrial dysfunction is central to degeneration of retinal ganglion cells. As these cells do not regenerate, vision is irreversibly lost. Here we show reversal of visual dysfunction by a mitochondrially targeted adeno associated virus in transgenic mice harboring a G11778A mutation in the <jats:italic>ND4<\/jats:italic> subunit of complex I persists longterm and it is associated with reduced loss of RGCs and their axons, improved oxidative phosphorylation, persistence of transferred <jats:italic>ND4<\/jats:italic> DNA and transcription of <jats:italic>ND4<\/jats:italic> mRNA.<\/jats:p>","DOI":"10.1038\/s41598-018-23836-y","type":"journal-article","created":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T02:23:06Z","timestamp":1522290186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Longterm Reversal of Severe Visual Loss by Mitochondrial Gene Transfer in a Mouse Model of Leber Hereditary Optic Neuropathy"],"prefix":"10.1038","volume":"8","author":[{"given":"Hong","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Porciatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Hauswirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Guy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,3]]},"reference":[{"key":"23836_CR1","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley, H. A. & Broman, A. T. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 90, 262\u2013267 (2006).","journal-title":"Br J Ophthalmol."},{"key":"23836_CR2","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1126\/science.aal5060","volume":"356","author":"B Laha","year":"2017","unstructured":"Laha, B., Stafford, B. K. & Huberman, A. D. Regenerating optic pathways from the eye to the brain. Science. 356, 1031\u20131034 (2017).","journal-title":"Science."},{"key":"23836_CR3","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1126\/science.aal0092","volume":"355","author":"PA Williams","year":"2017","unstructured":"Williams, P. A. et al. Vitamin B3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice. Science 355, 756\u2013760 (2017).","journal-title":"Science"},{"key":"23836_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1136\/jmg.2007.054270","volume":"46","author":"P Yu-Wai-Man","year":"2009","unstructured":"Yu-Wai-Man, P. et al. Inherited mitochondrial optic neuropathies. J Med Genet. 46, 145\u2013158 (2009).","journal-title":"J Med Genet."},{"key":"23836_CR5","unstructured":"Yu-Wai-Man, P. & Chinnery, P. F. Leber Hereditary Optic Neuropathy. In: Adam M. P. et al., editors. SourceGeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; (1993)."},{"key":"23836_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.preteyeres.2010.11.002","volume":"30","author":"P Yu-Wai-Man","year":"2011","unstructured":"Yu-Wai-Man, P., Griffiths, P. G. & Chinnery, P. F. Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies. Prog Retin Eye Res 30, 81\u2013114 (2011).","journal-title":"Prog Retin Eye Res"},{"key":"23836_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/WCO.0b013e32835c5f0b","volume":"26","author":"V Carelli","year":"2013","unstructured":"Carelli, V., La, M. C. & Sadun, A. A. Mitochondrial dysfunction in optic neuropathies: animal models and therapeutic options. Curr Opin Neurol. 26, 52\u201358 (2013).","journal-title":"Curr Opin Neurol."},{"issue":"20","key":"23836_CR8","doi-asserted-by":"publisher","first-page":"E1238","DOI":"10.1073\/pnas.1119577109","volume":"109","author":"H Yu","year":"2012","unstructured":"Yu, H. et al. Gene delivery to mitochondria by targeting modified adenoassociated virus suppresses Leber\u2019s hereditary optic neuropathy in a mouse model. Proc Natl Acad Sci USA 109(20), E1238\u201347 (2012).","journal-title":"Proc Natl Acad Sci USA"},{"key":"23836_CR9","doi-asserted-by":"publisher","first-page":"E5689","DOI":"10.1073\/pnas.1506129112","volume":"112","author":"H Yu","year":"2015","unstructured":"Yu, H. et al. Consequences of zygote injection and germline transfer of mutant human mitochondrial DNA in mice. Proc Natl Acad Sci USA 112, E5689\u2013E5698 (2015).","journal-title":"Proc Natl Acad Sci USA"},{"key":"23836_CR10","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1056\/NEJMoa1412965","volume":"372","author":"SG Jacobson","year":"2015","unstructured":"Jacobson, S. G. et al. Improvement and decline in vision with gene therapy in childhood blindness3. N Engl J Med. 372, 1920\u20131926 (2015).","journal-title":"N Engl J Med."},{"key":"23836_CR11","doi-asserted-by":"crossref","unstructured":"Banitt, M. R. et al. Progressive loss of retinal ganglion cell function precedes structural loss by several years in glaucoma suspects. Invest Ophthalmol Vis Sci. 54, 2346-2352 (2013).","DOI":"10.1167\/iovs.12-11026"},{"key":"23836_CR12","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1055\/s-0033-1350786","volume":"230","author":"C Kernstock","year":"2013","unstructured":"Kernstock, C., Friebe, K. & Tonagel, F. Applications of optical coherence tomography (OCT) in neuro-ophthalmology. Klin Monbl Augenheilkd. 230, 1097\u20131105 (2013).","journal-title":"Klin Monbl Augenheilkd."},{"key":"23836_CR13","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1001\/jamaophthalmol.2013.7971","volume":"132","author":"BL Lam","year":"2014","unstructured":"Lam, B. L. et al. Trial end points and natural history in patients with G11778A Leber hereditary optic neuropathy: preparation for gene therapy clinical trial. JAMA Ophthalmol. 132, 428\u2013436 (2014).","journal-title":"JAMA Ophthalmol."},{"key":"23836_CR14","first-page":"223","volume":"98","author":"AA Sadun","year":"2000","unstructured":"Sadun, A. A. et al. Leber\u2019s hereditary optic neuropathy differentially affects smaller axons in the optic nerve. Trans Am Ophthalmol Soc. 98, 223\u2013232 (2000).","journal-title":"Trans Am Ophthalmol Soc."},{"key":"23836_CR15","first-page":"1668","volume":"18","author":"H Yu","year":"2012","unstructured":"Yu, H. et al. Mutant NADH dehydrogenase subunit 4 gene delivery to mitochondria by targeting sequence-modified adeno-associated virus induces visual loss and optic atrophy in mice. Mol Vis. 18, 1668\u20131683 (2012).","journal-title":"Mol Vis."},{"key":"23836_CR16","unstructured":"Araujo Zin, E. et al. Optimization of AAV-mediated Gene Delivery for Targeting Mitochondria in the Outer Retina and M\u00fcller glia. IOVS Supplr ARVO meeting Baltimore USA Abstract Number: 4090\u2013B0090 (2017)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23836-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23836-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23836-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T04:09:32Z","timestamp":1671595772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-23836-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,3]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["23836"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-23836-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,3]]},"assertion":[{"value":"7 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"John Guy has a conflict in that he owns the intellectual property for the mito-targeted AAV. William Hauswirth has financial interest in a company AGTC that commercializes AAV vectors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5587"}}